---
figid: PMC8039382__fonc-11-626577-g0002
figtitle: Metabolic and signaling networks involved in anoikis-resistance mechanism
organisms:
- Homo sapiens
- Mus musculus
- Hepatitis B virus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8039382
filename: fonc-11-626577-g0002.jpg
figlink: pmc/articles/PMC8039382/figure/F2/
number: F2
caption: Metabolic and signaling networks involved in anoikis-resistance mechanism.
  Several metabolic intermediates generate the energy required for cellular growth
  and survival; oncogenic activation of signaling pathways reprogram cellular metabolism
  to promote anoikis resistance. Metabolic pathways occur in different compartments,
  which involve the biosynthesis or degradation of biomolecules to supply energy needs
  of the cell. Glycolysis, PPP, protein, fatty acid, and nucleotide biosynthesis take
  place in the cytosol, while TCA and FAO occur in the mitochondria. The decarboxylation
  of pyruvate to acetyl-CoA takes place in the mitochondrial matrix. These metabolic
  pathways are interrelated with acetyl-CoA, which acts a key substrate for connecting
  these pathways. Metabolism is regulated by rate-limiting enzymes that allow the
  cell to maintain cellular homeostasis. However, the dysregulation of genes encoding
  these enzymes leads to metabolic perturbation that drives anoikis resistance preceding
  tumor metastasis. 6PGL, 6-Phosphogluconolactone; AMPK, Adenosine Monophosphate Kinase;
  ACC1, Acetyl Carboxylase 1; ATP, Adenosine Triphosphate; CSN, Citrate Synthase;
  EGFR, Epidermal Growth Factor Receptors; EMT, Epithelial-Mesenchymal Transition;
  ERK, Extracellular-Signal-Regulated Kinase; FAO, Fatty Acid Oxidation; FASN, Fatty
  Acid Synthase; FATP, Fatty Acid Transport Proteins; G3P, Glyceraldehyde-3-Phosphate;
  G6P, Glucose-6-Phosphate; G6PDH, Glucose-6-Phosphate Dehydrogenase; GLUT, Glucose
  Transporters; HIF, Hypoxia-Inducible Factors; HK, Hexokinase; IGFR, Insulin-Like
  Growth Factor-1 Receptor; LKB1, Liver Kinase B1; MAPK, Mitogen-Activated Protein
  Kinase; mTOR, Mammalian Target of Rapamycin; NF-κB, Nuclear Factor-Kappa B; PDH,
  Pyruvate Dehydrogenase; PEP, Phosphoenolpyruvate; PI3K, Phosphatidylinositol 3-Kinase;
  PPP, Pentose Phosphate Pathway; PTEN, Phosphatase and Tensin; ROS, Reactive Oxygen
  Species; STAT3, Signal Transducer and Activator of Transcription 3; TCA, Tricarboxylic
  Acid; TGF-β, Transforming Growth Factor-Beta; VLCFA, Very Long-Chain Fatty Acid.
papertitle: Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance
  of Metabolic Reprogramming.
reftext: Funmilayo O. Adeshakin, et al. Front Oncol. 2021;11:626577.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9350195
figid_alias: PMC8039382__F2
figtype: Figure
redirect_from: /figures/PMC8039382__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8039382__fonc-11-626577-g0002.html
  '@type': Dataset
  description: Metabolic and signaling networks involved in anoikis-resistance mechanism.
    Several metabolic intermediates generate the energy required for cellular growth
    and survival; oncogenic activation of signaling pathways reprogram cellular metabolism
    to promote anoikis resistance. Metabolic pathways occur in different compartments,
    which involve the biosynthesis or degradation of biomolecules to supply energy
    needs of the cell. Glycolysis, PPP, protein, fatty acid, and nucleotide biosynthesis
    take place in the cytosol, while TCA and FAO occur in the mitochondria. The decarboxylation
    of pyruvate to acetyl-CoA takes place in the mitochondrial matrix. These metabolic
    pathways are interrelated with acetyl-CoA, which acts a key substrate for connecting
    these pathways. Metabolism is regulated by rate-limiting enzymes that allow the
    cell to maintain cellular homeostasis. However, the dysregulation of genes encoding
    these enzymes leads to metabolic perturbation that drives anoikis resistance preceding
    tumor metastasis. 6PGL, 6-Phosphogluconolactone; AMPK, Adenosine Monophosphate
    Kinase; ACC1, Acetyl Carboxylase 1; ATP, Adenosine Triphosphate; CSN, Citrate
    Synthase; EGFR, Epidermal Growth Factor Receptors; EMT, Epithelial-Mesenchymal
    Transition; ERK, Extracellular-Signal-Regulated Kinase; FAO, Fatty Acid Oxidation;
    FASN, Fatty Acid Synthase; FATP, Fatty Acid Transport Proteins; G3P, Glyceraldehyde-3-Phosphate;
    G6P, Glucose-6-Phosphate; G6PDH, Glucose-6-Phosphate Dehydrogenase; GLUT, Glucose
    Transporters; HIF, Hypoxia-Inducible Factors; HK, Hexokinase; IGFR, Insulin-Like
    Growth Factor-1 Receptor; LKB1, Liver Kinase B1; MAPK, Mitogen-Activated Protein
    Kinase; mTOR, Mammalian Target of Rapamycin; NF-κB, Nuclear Factor-Kappa B; PDH,
    Pyruvate Dehydrogenase; PEP, Phosphoenolpyruvate; PI3K, Phosphatidylinositol 3-Kinase;
    PPP, Pentose Phosphate Pathway; PTEN, Phosphatase and Tensin; ROS, Reactive Oxygen
    Species; STAT3, Signal Transducer and Activator of Transcription 3; TCA, Tricarboxylic
    Acid; TGF-β, Transforming Growth Factor-Beta; VLCFA, Very Long-Chain Fatty Acid.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Akt1
  - Slc1a3
  - Pik3r1
  - Slc27a1
  - ras
  - Hras
  - Kras
  - Rem1
  - Pten
  - Stk11
  - Mtor
  - Apk
  - Hk
  - Gnat2
  - Hps3
  - Csn
  - Nfkb1
  - Myc
  - Nol3
  - Acaca
  - Tgfb1
  - Ltbp1
  - Ephb2
  - Mapk1
  - Itk
  - Slc22a3
  - Fasn
  - Stat3
  - Egfr
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - IGF1R
  - AKT1
  - AKT2
  - AKT3
  - SLC2A1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SLC27A1
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - STK11
  - MTOR
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - H6PD
  - PGLS
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - NFKB1
  - MYC
  - ACACA
  - BCL2A1
  - TGFB1
  - TGFB2
  - TGFB3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - EPHB2
  - MAPK1
  - MAPK3
  - ITK
  - SLC22A3
  - FASN
  - STAT3
  - EGFR
  - Akt
  - Eaat1
  - Glut1
  - Glut4EF
  - Glut3
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Fatp1
  - Ras64B
  - Ras85D
  - Lkb1
  - Tor
  - Nplp1
  - Zw
  - G6P
  - Pgls
  - amon
  - CycE
  - cyc
  - Pdh
  - Pdha
  - Pdf
  - Pdhb
  - Coa
  - Dif
  - dl
  - Rel
  - dpp
  - gbb
  - put
  - mav
  - SNF4Agamma
  - AMPKalpha
  - Erk7
  - rl
  - FASN1
  - FASN2
  - Glucose
  - TCA
  - Citrate
  - Glutamine
  - Pyruvate
  - Acetyl CoA
  - Malonyl
  - Fatty Acid
  - Fatty acid
  - Acidosis
---
